Exiger warns the U.S. is overly reliant on foreign countries to make key components of crucial medications as the Trump ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...

Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...

Russia's president Vladimir Putin has appointed a little known company to manage assets linked to major German pharmaceutical ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and ...